Science
Mechanism of Action
The primary mechanism of Dinonoxynol-9 Citrate, attributed to its Nonoxynol-9 core, involves its role as a nonionic surfactant. It interacts with and disrupts the lipid components of cellular membranes, causing them to lyse (rupture). This leads to the leakage of intracellular contents and ultimately cell death, a process which is not exclusively selective and can impact various cell types and microorganisms.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 A 2% solution of Nonoxynol-8.3 and -9 demonstrated sensitizing potential in patients with dermatitis, suggesting a risk for allergic reactions or heightened skin sensitivity.
- 02 Clinical investigations involving Nonoxynol-9 revealed irritation of mucous membranes and increased epithelial disruption, indicating its capacity to compromise tissue integrity.
- 03 Long-term, dose-dependent use of nonoxynol-9 led to shifts in vaginal flora, including an increase in anaerobic gram-negative rods and bacterial vaginosis, although most users experienced minimal overall disruption.
- 04 An intravaginal gel containing 52.5 mg of nonoxynol-9 was associated with a significantly higher incidence of gonorrhea in a clinical trial, potentially due to the ingredient's membrane-disrupting action increasing susceptibility to infection.
Transparency
Dusting Analysis
There is no available data to indicate that Dinonoxynol-9 Citrate is commonly 'dusted' or used at concentrations that pose a specific dusting risk in typical skincare formulations.
The Formula
Formulation
Conflicts
- Oil-based lubricants (e.g., petroleum jelly, cooking oils, certain face or body creams) should be avoided with products containing Nonoxynol-9 if used in conjunction with latex contraceptives (condoms, cervical caps), as they can weaken or break the latex material. Water-based lubricants are recommended in such scenarios.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel concluded that Nonoxynols-9 and similar variants are safe for use in cosmetics when formulated to be non-irritating. However, the FDA has issued warnings that Nonoxynol-9, when used as a spermicide, offers no protection against HIV/AIDS or other sexually transmitted diseases and may increase the risk of transmission due to its potential to cause vaginal or rectal irritation. Although a specific maximum safe concentration for Dinonoxynol-9 Citrate in general leave-on skincare is not provided by CIR, sensitization was observed at 2% in dermatitis patients. The inherent membrane-disrupting mechanism warrants caution for maintaining skin barrier integrity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to demonstrated high irritancy and sensitization risks in clinical data, its non-selective membrane-disrupting mechanism, and the absence of specific positive skincare benefits, Dinonoxynol-9 Citrate is not recommended for use in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…